Repurposing Conventional Magnetic Functional Agents: A Novel Strategy for Long-Acting, Safe, Magnetically Mediated Precision Oncology
Pharmaceutics · 02.03.2026 · 18 (3) · 319
DOI: 10.3390/pharmaceutics18030319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 02.03.2026. Verfasst von Zihan Lv und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Materials Science, Shenzhen MSU-BIT University, Shenzhen 518172, China. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Scientific and Technological Project, Project of Innovation of the Science and Technology Commission of Shenzhen City.
Abstract (Originalsprache)
Background
Although conventional magnetic functional agents provide a material basis for magnetically mediated tumor therapy, they have long been restricted by the application framework of magnetic resonance imaging (MRI) or magnetic thermal ablation.
Methods
This study proposed a repurposing strategy of two mature magnetic functional agents, Fe3O4 nanoparticles and gadopentetic acid (GA), by applying their unique magnetic response properties to enhance magnetic field therapy for glioma.
Results
Both magnetic materials, when combined with an external magnetic field (MF), showed a synergistic effect to amplify the therapeutic effect. In the CT-2A glioma-bearing mice model, it resulted in marked suppression of tumor growth, with the growth inhibition (TGI) rate increasing from ~27% after MF therapy alone to 64% and 55% after the Fe3O4- and GA-potentiated MF therapy, respectively. It was proposed that the MF effect on impairing tumor angiogenesis was enhanced, as evidenced by significant reductions in CD31 expression and microvessel density. It disrupted nutrient supply to the tumor, augmenting the tumor suppression efficiency. The reduced infiltration of CD4+ and CD8+ T cells into tumors further confirmed the effective blockade of tumor perfusion.
Conclusions
This study established a new paradigm of conventional magnetic materials to enhance the non-thermal physical effects and biological regulatory effects of magnetic field for glioma therapy, instead of only as the imaging agents or magnetic hyperthermia agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Materials Science, Shenzhen MSU-BIT University, Shenzhen 518172, China.
- Shenzhen Children's Hospital, Shenzhen 518038, China.
- Affiliated Shenzhen Children's Hospital of Shantou University Medical College, Shenzhen 518038, China.
Förderung
- National Natural Science Foundation of China
- Guangdong Scientific and Technological Project
- Project of Innovation of the Science and Technology Commission of Shenzhen City
- Guangdong Provincial University Key Research Project
- Science and Technology Innovation Commission of Shenzhen
Zitieren
APA
Lv, Z., Wang, Y., Su, Y., Yu, A., He, R., Xie, Z., & Zhu, Y. (2026). Repurposing Conventional Magnetic Functional Agents: A Novel Strategy for Long-Acting, Safe, Magnetically Mediated Precision Oncology. Pharmaceutics, 18(3), 319. https://doi.org/10.3390/pharmaceutics18030319
Vancouver
Lv Z, Wang Y, Su Y, Yu A, He R, Xie Z, et al. Repurposing Conventional Magnetic Functional Agents: A Novel Strategy for Long-Acting, Safe, Magnetically Mediated Precision Oncology. Pharmaceutics. 2026;18(3):319. doi:10.3390/pharmaceutics18030319
BibTeX
@article{Lv2026,
author = {Lv, Zihan and Wang, Yue and Su, Yimin and Yu, Albert and He, Rouye and Xie, Zhongjian and Zhu, Yao},
title = {Repurposing Conventional Magnetic Functional Agents: A Novel Strategy for Long-Acting, Safe, Magnetically Mediated Precision Oncology},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {3},
pages = {319},
doi = {10.3390/pharmaceutics18030319}
}
EUVIMED